-

Continuing Medical Education – Continuing Professional Development (CME-CPD) Accreditation

The 'European Academy of Dermatology and Venereology (EADV)' (or) '22nd EADV Congress' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the
European Union of Medical Specialists (UEMS), www.uems.net.

The '22nd EADV Congress' is designated for a maximum of (or 'for up to') 21 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at:

 www.ama-assn.org/go/internationalcme

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

EACCME credits

Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

Dear Colleagues and Friends,

On behalf of the Local Organising Committee and the Turkish Society of Dermatology, we are delighted to invite you to Istanbul to participate in the 22nd EADV Congress that will be held from 3-6 October, 2013. 

After the successful 5th EADV Spring Symposium in 2008, it is now a great pleasure to welcome you back to Istanbul, one of the most attractive, historical cities in the world. Istanbul is the city that bridges Europe and Asia, which you will be able to observe through the windows of the Congress Venue ICC. The new Congress venue is in the heart of the city and there are many hotels within walking distance.

 The 22nd EADV Congress will be run under the theme of “Dermatovenereology in a changing world”. In the industrially as well as socially changing world, dermatovenereology is becoming more and more popular. The latest developmental efforts within industry have provided us with new drugs and modalities that facilitate both the diagnosis and treatment of many diseases. Moreover, these developments have led to great improvements especially in cosmetic dermatology. Both in our country and in many others, dermatovenereology has become a popular area of medical expertise and the leading choice of young doctors, which further increases the medical as well as societal impact of dermatology in this new era. 

Thanks to the great efforts of the EADV’s Scientific Programming Committee and the Local Scientific Committee, an outstanding programme is now ready that covers many fields of dermatology and its interesting, recent developments. We believe that our meeting will present high level scientific knowledge with the contribution of leading dermatologists and many specialists who are experts in their fields. 

We are looking forward to welcoming dermatologists from all over the world to Istanbul to witness an unforgettable scientific event and feel the fascinating atmosphere of this metropolis.

Rooms at special conference rates will be held in hotels of different categories. A number of hotels have been pre-booked for the 22nd EADV Congress. Rooms will be allocated on a first come, first served basis. The rates are per room, per night, including breakfast and local VAT.

Submission Info

• Abstracts must be submitted in English. A “blind” selection process will be used. No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. Their names and affiliations (institutions) will be registered separately when submitting the abstract online.
• The material in the abstract must be original and not previously published.
• The title should be as brief as possible but long enough to clearly indicate the nature of the study. Abbreviations must not be used in the title.
• The size of the abstract is limited to 3,000 characters (this includes title, body of abstract, spaces, tables and graphics). The submission programme will automatically calculate the size of your abstract and will not allow submissions that do not fit in the size requirements. Each section (Introduction & Objectives, Materials & Methods, Results, and Conclusions) should be inserted in the individually labelled boxes.
• You can click on the relevant icons to insert tables, pictures or specific characters.
• Structure your abstract using the following subheadings:
  • Introduction & Objectives: A sentence describing the purpose of the study
  • Materials & Methods: Describe your selection of observations or experimental subjects precisely
  • Results: Describe your results in a logical sequence
  • Conclusions: Emphasise new and important aspects of the study and conclusions that are drawn from them
• Failure to comply with the following requirements will lead to automatic rejection of the submission:
  • Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted.
  • Use generic names. Commercial drug names may not be used. Drugs should be referred to by the active substance or pharmacological designation.
  • No mention of pharmaceutical company names should be included in the abstract.
• The evaluation and scoring of the abstract (acceptance as poster or as oral communication, or rejection) will be made according to a number of criteria, including:
  • Is the content interesting, informative, novel or important?
  • Are the methods valid, the results relevant and the conclusions justified by the data?
  • Are the data presented with clarity and with appropriate structure?
  • Is the text written according to proper English grammar and syntactic style?
• The authors have to specify if they wish the submission to presented as:
  • Poster presentation only
  • Oral presentation only (that is, if rejection of the abstract, no communication!)
  • Poster or oral presentation